Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Nilutamide

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,406Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pfizer, Astellas' Xtandi racks up more data for new prostate cancer approval
    Pfizer, Astellas' Xtandi racks up more data for new prostate cancer approval

    03 Jun 2019

    // Carly Helfand FIERCE PHARMA

    https://www.fiercepharma.com/pharma/asco-pfizer-astellas-xtandi-racks-up-more-data-for-new-prostate-cancer-use

    Carly Helfand FIERCE PHARMA
    03 Jun 2019
    Share Share
    Drug flippers exploit pharma's price-hike climate for fast profit
    Drug flippers exploit pharma's price-hike climate for fast profit

    03 Nov 2016

    // Carly Helfand FIERCE PHARMA

    http://www.fiercepharma.com/pharma/drug-flippers-exploit-pharma-s-price-hike-climate-for-fast-profit

    Carly Helfand FIERCE PHARMA
    03 Nov 2016
    Share Share
    ANI Pharmaceuticals Announces FDA Approval & Immediate Launch of Nilutamide
    ANI Pharmaceuticals Announces FDA Approval & Immediate Launch of Nilutamide

    18 Jul 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/ani-pharmaceuticals-announces-fda-approval-immediate-launch-of-nilutamide-1469095035.pdf

    FDA
    18 Jul 2016
    Share Share
    Concordia Healthcare to Buy Some Assets of Covis Pharma for $1.2 Billion
    Concordia Healthcare to Buy Some Assets of Covis Pharma for $1.2 Billion

    10 Mar 2015

    // Sneha Banerjee REUTERS

    http://www.reuters.com/article/2015/03/09/us-covis-phrama-m-a-concordia-hlthcr-idUSKBN0M50XS20150309

    Sneha Banerjee REUTERS
    10 Mar 2015
    Share Share